Last updated: July 12, 2026

Application No. 18/710,596

Untitled Application

Unknown

Filed

Priority

Nov 22, 2021 — CN 202111383481.5 +1 more

Examiner

RICCI, CRAIG D

Art Unit

Tech Center

SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES

Assignee

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

OA Round

1 (Non-Final)

This examiner grants 53% of cases after interview

— +52.7% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 1147 resolved cases, 2023–2026

Examiner Intelligence

RICCI, CRAIG D View full profile →

Grants 53% of resolved cases

Career Allowance Rate

613 granted / 1147 resolved

-6.6% vs TC avg

Strong +53% interview lift

Without

With

+52.7%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

68 currently pending

Career history

1208

Total Applications

across all art units

Statute-Specific Performance

§101

0.1%

-39.9% vs TC avg

§103

49.7%

+9.7% vs TC avg

§102

11.5%

-28.5% vs TC avg

§112

8.1%

-31.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1147 resolved cases

Prosecution Timeline

May 06, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/783,734

Patent 12673040

PHARMACEUTICAL COMPOSITION FOR TREATING MIGRAINE

1y 11m to grant Granted Jul 07, 2026

17/762,443

Patent 12662452

SOLID STATE FORMS OF LUCERASTAT AND PROCESS FOR PREPARATION THEREOF

4y 3m to grant Granted Jun 23, 2026

18/613,333

Patent 12661321

SINGLE-INJECTION METHODS AND FORMULATIONS TO INDUCE AND CONTROL MULTIPLE OVARIAN FOLLICLES IN BOVINE, CAPRINE, OVINE, CAMELID AND OTHER FEMALE ANIMALS

2y 3m to grant Granted Jun 23, 2026

17/048,897

Patent 12655156

OXADIAZOLOPYRAZINES AND OXADIAZOLOPYRIDINES USEFUL AS MITOCHONDRIAL UNCOUPLERS

5y 8m to grant Granted Jun 16, 2026

17/844,934

Patent 12653769

ENHANCING PHOTOSTABILITY OF THIOPYRIDINONE COMPOUND WITHOUT THE USE OF UV FILTERS

3y 12m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

53%

Grant Probability

99%

With Interview (+52.7%)

3y 3m

Median Time to Grant

Low

PTA Risk

Based on 1147 resolved cases by this examiner. Grant probability derived from career allowance rate.